Lisa Tannock Takes on New Roles at Queen’s University

On March 18, Queen’s University in Kington, Ontario, Canada, announced that Lisa Tannock, MD, was appointed dean, Queen’s Health Sciences, and director of the School Medicine, effective July 1.

Tannock will join Queen’s University from the University of Kentucky, where she is associate provost for faculty advancement and a professor in the Division of Endocrinology, Diabetes, and Metabolism. In her role as dean of Queen’s Health Sciences, Tannock will lead a faculty that includes the School of Medicine, the School of Nursing, and the School of Rehabilitation Therapy.

Tannock completed her medical degree and residency training in internal medicine at the University of Toronto and then completed a fellowship at the University of Washington Medical Center in Seattle. She joined the University of Kentucky in 2004, and she has since served in several leadership roles, including division chief, associate chair of internal medicine for administration, and vice-dean for faculty affairs.

“I am very excited to be returning to Canada, beginning an exciting new opportunity as dean of Queen’s Health Sciences, and joining its community of talented faculty, staff, and students,” Tannock says. “Queen’s Health Sciences has a long history of excellence and a deep commitment to innovative and interdisciplinary research and teaching, and I look forward to engaging with colleagues to find new ways to advance the faculty’s mission and its significant partnerships.”

In her role as associate provost for faculty advancement, Tannock has overseen faculty development, recruitment and retention, and leadership training across the campus. As a clinician-scientist, Tannock’s research activity has focused on the role of inflammation and lipid metabolism in cardiovascular diseases associated with diabetes, as well as on the development of complications from diabetes and obesity. Tannock’s clinical interests also include diabetes and insulin resistance, cholesterol disorders, and transgender medicine. She has served as a mentor to numerous trainees at all levels and many of her publications are co-authored by them.

Tannock will also take on the role of CEO of the Southeastern Ontario Academic Medical Organization (SEAMO)

You may also like

  • Webinar Will Examine Concerns Around Compounding Anti-Obesity Medications

    Endocrine Society to host virtual Science Writers Conference Nov. 14 Surging demand for a new generation of highly effective anti-obesity medications is creating interest in compounded versions of these medications. Endocrine Society experts will discuss the importance of prescribing FDA-approved medications to treat obesity during the Society’s Virtual Science Writers Conference on November 14. What:…

  • Bianco Named Vice President and Vice Provost for Research, Chief Research Officer at UTMB

    Antonio Bianco, MD, PhD, has joined the University of Texas Medical Branch (UTMB) as vice president and vice provost, research, and chief research officer, effective Sept. 1. A renowned physician-scientist, scholar, and research leader, Bianco possesses an impressive academic career that includes influential contributions to the field of thyroid diseases and an enduring commitment to…

Find more in